Northwire Canada EditionWednesday, July 29, 2026
Northwire
NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0%
Financings

Intermap increases bought deal to $25-million

IMP · Price

Executive Summary

  • Intermap Technologies Corp. has increased the size of its previously announced bought deal financing from $20.1 million to $25 million due to strong investor demand.
  • The company is issuing 8,334,000 Class A common shares at $3.00 per share, generating aggregate gross proceeds of $25,002,000.
  • The underwriters retain an option to purchase up to 1,250,100 additional shares for overallotment, which would increase total gross proceeds to $28,752,300.

Key Details

  • Transaction Structure: Bought deal financing via a syndicate of underwriters including Stifel Canada, Canaccord Genuity Corp., and Beacon Securities Ltd.
  • Share Price: $3.00 per Class A common share.
  • Base Proceeds: 8,334,000 shares issued for aggregate gross proceeds of $25,002,000.
  • Overallotment Option: Underwriters have the option to purchase up to 1,250,100 additional common shares within 30 days of closing.
  • Maximum Proceeds: If the overallotment option is exercised in full, total gross proceeds will reach $28,752,300.
  • Use of Proceeds: Net proceeds will be used for working capital and general corporate purposes.
  • Closing Date: Scheduled for on or about September 29, 2025.
  • Regulatory Status: Subject to conditions including receipt of necessary approvals, specifically the conditional approval of the Toronto Stock Exchange.
  • Distribution Method: Offered via a shelf prospectus supplement in Canadian provinces (excluding Quebec) under National Instrument 44-102, and in the United States on a private placement basis to qualified institutional buyers under Rule 144A.
Read the original news release →

More from Intermap Technologies Corp